Literature DB >> 29551424

Mouse model demonstrates strain differences in susceptibility to opioid side effects.

Andrew Young1, Archana Viswanath2, Mythili Kalladka3, Junad Khan4, Eli Eliav5, Scott R Diehl6.   

Abstract

Individual differences have been observed in responses to opioid drugs, including common side effects. In this study, the inbred mouse strains A/J and C57BL/6J were used to determine whether their specific strain differences correlate with differences in susceptibility to respiratory depression and constipation. To measure the effects of morphine on respiration, morphine at 15 and 40 mg/kg was injected subcutaneously. Respiratory parameters were then measured 30 and 60 min later. To measure the effects on constipation, 5, 15, 40, and 60 mg/kg doses were administered subcutaneously three times daily for three days. Gastrointestinal transit distance was then measured using the charcoal bolus test. C57BL/6J mice showed a greater degree of change in several respiratory parameters, resulting in more pronounced respiratory depression. C57BL6J mice also showed significantly more constipation than A/J mice with 40 and 60 mg/kg morphine doses. This study demonstrates that the strain differences between A/J and C57BL/6J mice have a major effect on opioid-induced constipation and respiratory depression. These correlations are of great clinical interest, as they could lead to the development of methods for reducing side effects.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Constipation; Opioid; Respiratory depression; Strain

Mesh:

Substances:

Year:  2018        PMID: 29551424     DOI: 10.1016/j.neulet.2018.03.022

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Fentanyl-induced acute and conditioned behaviors in two inbred mouse lines: Potential role for Glyoxalase.

Authors:  Samuel J Harp; Mariangela Martini; Will Rosenow; Larry D Mesner; Hugh Johnson; Charles R Farber; Emilie F Rissman
Journal:  Physiol Behav       Date:  2021-10-26

2.  μ-Opioid Receptor-Mediated Enteric Glial Activation Is Involved in Morphine-Induced Constipation.

Authors:  Hui Gao; Yuxin Zhang; Yansong Li; Haiqing Chang; Bo Cheng; Na Li; Wei Yuan; Shuang Li; Qiang Wang
Journal:  Mol Neurobiol       Date:  2021-02-23       Impact factor: 5.590

3.  The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids.

Authors:  Rebecca Speltz; Mary M Lunzer; Sarah S Shueb; Eyup Akgün; Rachelle Reed; Alex Kalyuzhny; Philip S Portoghese; Donald A Simone
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

Review 4.  Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology.

Authors:  Rob Hill; Meritxell Canals
Journal:  Pharmacol Ther       Date:  2021-07-10       Impact factor: 12.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.